Prednisone in Uric Acid Lowering in Symptomatic Heart Failure Patients with Hyperuricemia -- The PUSH-PATH3 Study

J Rheumatol. 2015 May;42(5):866-9. doi: 10.3899/jrheum.141037. Epub 2015 Mar 15.

Abstract

Objective: To determine the safety and efficacy of prednisone in patients with symptomatic heart failure (HF) and hyperuricemia.

Methods: Prednisone therapy was administered for a short time to 191 symptomatic HF patients with hyperuricemia (serum uric acid > 7 mg/dl).

Results: Prednisone significantly reduced serum uric acid by 2.99 mg/dl (p < 0.01) and serum creatinine by 0.17 mg/dl (p < 0.01). These favorable effects were associated with a remarkable increase in urine output, improvement in renal function, and improvement in clinical status.

Conclusion: Prednisone can be used safely in symptomatic HF patients with hyperuricemia.

Keywords: HEART FAILURE; HYPERURICEMIA; PREDNISONE; RENAL FUNCTION.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Creatinine / blood
  • Female
  • Gout Suppressants / adverse effects
  • Gout Suppressants / therapeutic use*
  • Heart Failure / complications*
  • Humans
  • Hyperuricemia / complications
  • Hyperuricemia / drug therapy*
  • Male
  • Middle Aged
  • Prednisone / adverse effects
  • Prednisone / therapeutic use*
  • Treatment Outcome
  • Uric Acid / blood

Substances

  • Gout Suppressants
  • Uric Acid
  • Creatinine
  • Prednisone